ACIP voted to recommend that pregnant women receive a dose of Tdap during each pregnancy
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted 14-0 with one abstention to recommend that…
LigoCyte Pharmaceuticals was acquired Takeda Pharmaceutical
On Oct. 3, 2012, Takeda Pharmaceutical acquired LigoCyte for an upfront payment of $60 million, with future contingent…
The Connecticut Challenge Survivorship Clinic Opened at Yale Cancer Center
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
Oregon Health & Science University Received $125 Million Gift From Nike Founder
On Sept. 19, 2012, Oregon Health & Science University (OHSU) in Portland announced that it had received a…
Grateful family left more than $10 million to support OHSU
On Sept. 10, 2012, Oregon Health Science University (OHSU) announced the estate of Garthe and Grace Brown designated…
2012 Lasker awards honor scientists for groundbreaking medical research
On Sept. 10, 2012, the Albert and Mary Lasker Foundation announced winners of the annual Lasker Awards: Michael…
A new phlebovirus (Heartland virus) associated with severe febrile illness in Missouri published
On Aug. 30, 2012, a new phlebovirus, discovered in northwestern Missouri by Dr. Scott Folk of Heartland Regional…
Lucentis approved for treatment of diabetic macular edema
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
Human Genome Sciences was acquired by GlaxoSmithKline for $3.6 billion
On Aug. 3, 2012, GlaxoSmithKline announced that it had completed its acquisition of Human Genome Sciences for $3.6…
The Connecticut Development Authority was merged into Connecticut Innovations
On Jul. 31, 2012, the Connecticut Development Authority (CDA) was merged into Connecticut Innovations (CI) which was created…
The University of Kansas Cancer Center earned National Cancer Institute designation
On Jul. 12, 2012 the University of Kansas Cancer Center earned National Cancer Institute designation. Through efforts initially…
The FDA’s “Breakthrough Therapy Designation” was created
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
The NIH awarded $65 million grant to Institute for Translational Health Sciences to turn promising discoveries into patient care advances
On Jul. 9, 2012, the National Institutes of Health (NIH) announced it had awarded a $65 million five…
The Serum Institute of India acquired Bilthoven Biologicals from The Netherlands Government
On Jul. 4, 2012, the Serum Institute of India made its first International acquisition by acquiring Bilthoven Biologicals,…
The CDC responded to a multi-state outbreak of salmonella infections associated with raw tuna
On Jun. 26, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to a multi-state outbreak…
Rocky Mountain Biological Laboratory announced $10 million legacy campaign
On Jun. 25, 2012, the Rocky Mountain Biological Laboratory (RMBL) announced the unveiling of its Legacy Campaign, a…
Biotechnology | Disease | FDA | Vaccine
FDA approved HibMenCY vaccine for infants
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
Biotechnology | Infectious Disease | Polio | Vaccine | WHO
The European Region of the world was certified as polio-free
On Jun. 21, 2012, the European Region of the world was certified as polio-free. Certification followed years of…
Scientists decoded genome of bonobo
On Jun. 13, 2012, in a project led by the Max Planck Institute for Evolutionary Anthropology in Leipzig,…
The Human Microbiome Project milestone announced
On Jun. 13, 2012, the Human Microbiome Project announced the completion of a seminal study of microbial diversity….
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
Scientists decoded genome of Chagas disease
On Jun. 5, 2012, an international team of scientists decoded genome of Chagas disease. Previously, scientists had only…
U.S. Dept of HHS Inspector General released report titled “Vaccines for Children Program: Vulnerabilities in Vaccine Management”
On Jun. 5, 2012, the U.S. Department of Health and Human Services (HHS) Office of the Inspector General…
First patent application granted for CRISPR-Cas9 gene editing in all environments
On May 25, 2012, Drs. Jennifer Doudna, Emanulle Charpentier, Martin Jinek of UC Berkeley and Krzystof Chylinski of…
AZBio led a cross industry coalition to amend Arizona’s Open Records Law
May 22, 2012, AZBio led a cross industry coalition to amend Arizona’s Open Records Law to make the…
Biotechnology | Disease | FDA | Therapeutics
FDA approved orphan drug Elelyso to treat a form of Gaucher disease
On May 1, 2012, the U.S. Food and Drug Administration (FDA) approved new orphan drug Elelyso to treat…
Hologic acquired Gen-Probe for $37 billion
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
Treatment outcomes in black and white children with cancer was published
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
Biotechnology | Diagnostics | Medicine | Neurology | Non-Profit Research | Oncology | Therapeutics | U.S. Congress
The Golden Goose Award was founded
On Apr. 25, 2012, U.S. Representatives Jim Cooper (D-Tenn.), Charlie Dent (R-Pa.), and Robert J. Dold (R-Ill.) joined…
The USDA confirmed detection of Bovine Spongiform Encephalopathy (BSE) in California
On Apr. 24, 2012, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…